Pharming Group N.V (PHAR) EPS (Weighted Average and Diluted): 2020-2024
Historic EPS (Weighted Average and Diluted) for Pharming Group N.V (PHAR) over the last 4 years, with Dec 2024 value amounting to $0.00.
- Pharming Group N.V's EPS (Weighted Average and Diluted) rose 180.00% to $0.00 in Q4 2024 from the same period last year, while for Dec 2024 it was -$0.04, marking a year-over-year decrease of 2.78%. This contributed to the annual value of -$0.02 for FY2024, which is 12.50% down from last year.
- As of Q4 2024, Pharming Group N.V's EPS (Weighted Average and Diluted) stood at $0.00, which was up 300.00% from -$0.00 recorded in Q3 2024.
- Pharming Group N.V's 5-year EPS (Weighted Average and Diluted) high stood at $15.68 for Q1 2021, and its period low was -$15.64 during Q2 2021.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.00, with a median of -$0.00 in 2023.
- Data for Pharming Group N.V's EPS (Weighted Average and Diluted) shows a peak YoY increase of 1,400.00% (in 2022) and a maximum YoY decrease of 520.00% (in 2022) over the last 5 years.
- Pharming Group N.V's EPS (Weighted Average and Diluted) (Quarterly) stood at $0.02 in 2020, then plummeted by 68.75% to $0.01 in 2021, then crashed by 520.00% to -$0.02 in 2022, then skyrocketed by 76.19% to -$0.01 in 2023, then skyrocketed by 180.00% to $0.00 in 2024.
- Its last three reported values are $0.00 in Q4 2024, -$0.00 for Q3 2024, and -$0.02 during Q2 2024.